CRDL
Cardiol Therapeutics
CRDL
CRDL
33 hedge funds and large institutions have $10.7M invested in Cardiol Therapeutics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5.78% more ownership
Funds ownership: 3.74% → 9.52% (+5.8%)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Holders
33
Holding in Top 10
–
Calls
$2.05M
Puts
$296K
Top Buyers
| 1 | +$5.83M | |
| 2 | +$847K | |
| 3 | +$360K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$328K |
| 5 |
Goldman Sachs
New York
|
+$198K |
Top Sellers
| 1 | -$111K | |
| 2 | -$95.4K | |
| 3 | -$48.9K | |
| 4 |
Morgan Stanley
New York
|
-$33.9K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$20.4K |